Growth Metrics

Vanda Pharmaceuticals (VNDA) Other financing activities (2016 - 2018)

Vanda Pharmaceuticals' Other financing activities history spans 7 years, with the latest figure at $2.7 million for Q1 2018.

  • On a quarterly basis, Other financing activities rose 20.69% to $2.7 million in Q1 2018 year-over-year; TTM through Mar 2018 was $5.7 million, a 42.55% decrease, with the full-year FY2017 number at $5.3 million, down 32.25% from a year prior.
  • Other financing activities hit $2.7 million in Q1 2018 for Vanda Pharmaceuticals, up from $81000.0 in the prior quarter.
  • Over the last five years, Other financing activities for VNDA hit a ceiling of $5.9 million in Q3 2016 and a floor of -$2.0 million in Q2 2014.
  • Historically, Other financing activities has averaged $1.1 million across 5 years, with a median of $750000.0 in 2016.
  • The widest YoY moves for Other financing activities: up 122300.0% in 2014, down 353.08% in 2014.
  • Tracing VNDA's Other financing activities over 5 years: stood at -$2.0 million in 2014, then skyrocketed by 100.05% to $1000.0 in 2015, then skyrocketed by 74900.0% to $750000.0 in 2016, then crashed by 89.2% to $81000.0 in 2017, then skyrocketed by 3191.36% to $2.7 million in 2018.
  • Business Quant data shows Other financing activities for VNDA at $2.7 million in Q1 2018, $81000.0 in Q4 2017, and $768000.0 in Q3 2017.